CDK4 and malignant colon neoplasm: In pathological condition, RUNX1T1 is shown to promote microglial proliferation by regulating CDK4 [55], but represses the proliferation and increases 5-flurouracil (5-FU) sensitivity in a colon cancer cell line (HCT116) [56].